Air pollution, particularly fine particulate matter (PM2.5) found in dust, soot, and smoke, may trigger painful rheumatoid arthritis (RA) flares and increase disease activity, according to a new study published in the Annals of the Rheumatic Diseases (ARD), the EULAR Journal, by Elsevier. RA is a chronic autoimmune condition affecting an estimated 0.5% to 1% of adults worldwide, with its development and progression influenced by genetics, immune function, and environmental exposures, some of which are modifiable like smoking, temperature, humidity, and pollutants. 
While earlier studies linked polluted air to RA onset, researchers in South Korea investigated whether air pollution affects disease activity in those already diagnosed, following 1,070 RA patients over four years (2021–2024) through 12,583 outpatient visits and analyzing exposure to six pollutants including SO2, NO2, O3, CO, PM10, and PM2.5, while accounting for demographics, serologic status, medication use, socioeconomic conditions, and weather. 
The study found that higher PM2.5 concentrations, especially prolonged exposure over two weeks, were significantly associated with increased RA activity and flare risk, likely because these tiny particles enter the bloodstream, stimulate harmful reactive oxygen species, damage DNA, and activate inflammatory responses.  In an accompanying editorial, Jeffrey A. Sparks, MD, MMSc, from Harvard Medical School and Brigham and Women’s Hospital, states, "This is one of the largest studies to use robust methods to link air pollutants with RA disease activity. Considering rising levels of air pollutants, these results have significant clinical, biologic, and public health implications. 
They also further reinforce that inhalants may have broad implications for risk and progression of RA and perhaps other autoimmune diseases. From a clinical perspective, this may offer avenues to lower the risk of RA flares by avoiding air with poor quality and provide some potential explanation for otherwise idiosyncratic RA flares." 
Lead investigator Eun Bong Lee, MD, PhD, of Seoul National University, explains, "Our study found that higher PM2.5 concentration was associated with increased disease activity and flare risk, notably prolonged exposure to elevated PM2.5 over more than two weeks," and concludes, "Our study has important implications for public health policy making. 
While further studies are warranted to determine whether improving air quality can reduce disease activity in RA patients, we would recommend these patients avoid prolonged exposure to poor air quality, particularly high PM2.5 levels." 
Although additional research is needed to confirm whether reducing pollution directly lowers RA activity, the findings suggest limiting exposure during poor air quality periods is a practical precaution. Josef Smolen, MD, ARD Editor-in-Chief, adds, "As always, this paper underwent thorough peer review, and it was nice to learn that all reviewers agreed on the importance and interest of these findings.